Table 3 Confidence and educational needs of HCPs when interacting with patients about cannabis-based products
From: The attitudes, knowledge and confidence of healthcare professionals about cannabis-based products
Question that survey participants (N = 1310) were asked | Scale | Median score (IQR) | |
|---|---|---|---|
How comfortable are you in discussing cannabis-based products with your patients? | 1–7 (Not at all comfortable–extremely comfortable) | 6 (6–6) | |
How confident are you in providing your patients with the following information, so that you can together make a well-informed shared decision? | The legality and regulation of different cannabis-based products in your country | 1–7 (Not at all confident–extremely confident) | 6 (6–6) |
The evidence underpinning the risks and benefits of different cannabis-based products | 5 (3–6) | ||
To what extent do you agree with the following statement? I would feel more confident prescribing (dispensing) or recommending a cannabis-based product if it was reviewed and approved by a medicines regulator (e.g. FDA, EMA), compared with a cannabis-based product that does not have marketing authorization/approvala | 1–7 (Not at all–completely agree) | 6 (6–6) | |
To what extent do you feel that you would benefit from more information with regards to the following types of information? | Information on the legality and regulation of different cannabis-based products | 1–7 (No benefit at all–extremely beneficial) | 6 (6–6) |
Information on the neurobiology of cannabis-based products | 6 (5–6) | ||
Information on the scientific evidence of risks and benefits of different cannabis-based products | 6 (5–6) | ||
Information on the different types of product available, their cannabinoid content, strength and pharmacokinetics, and drug interaction potential | 6 (5–6) | ||